Serum levels of cardiac troponin I are not increased in patients on high-doses-methotrexate therapy

Abstract

Methotrexate abbreviated MTX and formerly known as amethopterin, is an antimetabolite and antifolate drug used in treatment of cancer and autoimmune diseases. It acts by inhibiting the metabolism of folic acid.

Keywords

• Cardiac toxicity
• Methotrexate
• Troponin I